Rafarma Pharmaceuticals, Inc. (WY) (RAFA, $0.07) was a top loser over the last three months, falling -5 to $0.07 per share. A.I.dvisor analyzed 203 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending June 13, 2025, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.